T cell exhaustion: Intricate balance of immune response and strategies

Tanze Emat^*
*Correspondence: Tanze Emat, Department of Immunology, Guangdong Medical University, Zhanjiang, China, Email:

Received: 17-Nov-2023, Manuscript No. AJIROA-23-123703 ; Editor assigned: 21-Nov-2023, Pre QC No. AJIROA-23-123703 (PQ); Reviewed: 05-Dec-2023, QC No. AJIROA-23-123703; Revised: 13-Dec-2023, Manuscript No. AJIROA-23-123703 (R); Published: 21-Dec-2023

Description

T cells, the linchpin of adaptive immunity, play a pivotal role in combating infections and cancer. However, in prolonged battles against persistent threats, T cells can enter a state of exhaustion, compromising their efficacy and altering immune responses. Understanding T cell exhaustion is paramount in deciphering immune dysfunction and devising strategies to revitalize immune defenses.

T cells exhaustion

Effector functions detailing the essential role of T cells in eliminating infected or malignant cells through cytokine secretion and cytotoxic activities (Adeegbe et al., 2013). Adaptive immunity examining how T cells remember and respond to specific threats, forming the cornerstone of immunological memory and chronic infections examining how prolonged exposure to pathogens, such as certain viruses or intracellular bacteria, can induce T cell exhaustion. Cancer microenvironment discussing the tumor-induced factors contributing to T cell exhaustion in the tumor milieu (Bettelli, et al., 2006).

Characteristics of T cell exhaustion

Loss of effector functions: Explaining how exhausted T cells gradually lose their ability to produce cytokines, proliferate, and execute cytotoxic activities.

Surface marker expression: Discussing the upregulation of certain inhibitory receptors, such as PD-1, Tim-3, and Lag-3, which are hallmarks of exhausted T cells (Curiel 2006).

Mechanisms and implications

Role of inhibitory receptors: Delving into how interactions between inhibitory receptors and their ligands impede T cell activation and function (Hori, et al., 2003).

Metabolic exhaustion: Examining the metabolic changes contributing to T cell dysfunction during exhaustion.

Chronic infections: Discussing the impact of T cell exhaustion on the persistence and progression of chronic infections.

Cancer Immunotherapy: Highlighting how understanding and targeting T cell exhaustion pathways have revolutionized cancer immunotherapies like immune checkpoint blockade.

Strategies and future directions

Checkpoint Inhibitors discussing the success and challenges of immune checkpoint blockade therapies in revitalizing exhausted T cells (Jia, et al., 2009). Metabolic interventions examining strategies to modulate metabolic pathways to enhance T cell function. Novel therapeutic avenues discussing emerging approaches to reverse T cell exhaustion and reinvigorate immune responses (Maoz, et al., 2019). Research frontiers highlighting ongoing studies aimed at understanding the nuances of T cell exhaustion for improved therapeutic outcomes (Miyara, et al., 2011). T cell exhaustion itself is not characterized by symptoms that individuals can perceive directly. Rather, it refers to a state of T cell dysfunction that occurs within the immune system, particularly in conditions of chronic infections, prolonged antigen exposure, or the tumor microenvironment (Natale, et al., 2017).

This state affects the functionality of T cells without producing outwardly visible or subjective symptoms in individuals (Nosbaum, et al., 2016). However, the consequences of T cell exhaustion can be observed indirectly through changes in immune responses, particularly in cases where T cell exhaustion leads to compromised immunity against infections or ineffective antitumor responses in cancer (Peyrot, et al., 2010). Symptoms or manifestations related to conditions associated with T cell exhaustion, rather than the exhaustion itself, might include:

Increased susceptibility to infections: T cell exhaustion can weaken the immune response against chronic infections, leading to persistent or recurrent infections.

Progression of chronic diseases: In chronic infections, the inability of exhausted T cells to effectively control the infection can result in the progression of the disease.

Cancer progression: In the context of cancer, T cell exhaustion can hinder the immune system's ability to recognize and eliminate cancer cells, contributing to tumor growth and progression.

Reduced response to therapies: In cancer immunotherapy, such as immune checkpoint blockade, insufficient responses might be observed due to pre-existing T cell exhaustion within the tumor microenvironment.

While T cell exhaustion itself doesn't manifest as distinct symptoms, its impact on the immune system's functionality can indirectly influence the progression of diseases or the effectiveness of immune-based therapies. T cell exhaustion stands as a critical checkpoint in immune function, shaping responses to chronic infections and cancer. Exploring the mechanisms and pathways underlying this state illuminates potential strategies to reinvigorate T cell responses, fostering a future where immune therapies mitigate immune dysfunction and bolster immune defenses.

References

1. Adeegbe DO, Nishikawa H (2013). Natural and induced T regulatory cells in cancer. Front Immunol. 4: 190.
2. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, et al. (2006).  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 441(7090):235-8.
3. Curiel TJ (2008). Regulatory T cells and treatment of cancer. Curr Opin Immunol. 20(2):241-6.
4. Hori S, Nomura T, Sakaguchi S (2003). Control of regulatory T cell development by the transcription factor Foxp3. Science. 299(5609):1057-61.
5. Jia T, Pamer EG (2009). Dispensable but not irrelevant. Science. 325:549-50.

   [Crossref] [Google Scholar][PubMed]

6. Maoz A, Dennis M, Greenson JK (2019). The Crohn's-like lymphoid reaction to colorectal cancer-tertiary lymphoid structures with immunologic and potentially therapeutic relevance in colorectal cancer. Front Immunol. 10:1884.

   [Crossref] [Google Scholar][PubMed]

7. Miyara M, Gorochov G, Ehrenstein M, Musset L, Sakaguchi S, Amoura Z (2011). Human FoxP3+ regulatory T cells in systemic autoimmune diseases. Autoimmun Rev. 10(12):744-55.
8. Natale G, Bocci G, Ribatti D(2017). Scholars and scientists in the history of the lymphatic system. J Anat. 231:417-29.

   [Crossref] [Google Scholar][PubMed]

9. Nosbaum A, Prevel N, Truong HA, Mehta P, Ettinger M, Scharschmidt TC, Ali NH, et al. (2016). Cutting edge: Regulatory T cells facilitate cutaneous wound healing. J Immunol. 196(5):2010-4.
10. Peyrot SM, Martin BL, Harland RM(2010). Lymph heart musculature is under distinct developmental control from lymphatic endothelium. Dev Biol. 339:429-38.

    [Crossref] [Google Scholar][PubMed]